Author

C. Palmieri

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 3 Approach:experimental assay· 2 Organism:human· 2 Research Focus:benchmarking· 1 Assay:ChIP-seq· 1 Research Focus:database / resource· 1 Approach:deep learning· 1 Research Focus:differential expression· 1

Frequent Co-Authors

A. M. Boddy· 1 shared A. S. Flies· 1 shared A. Saiakhova· 1 shared A. Vingiani· 1 shared B. Gyorffy· 1 shared C. Coombes· 1 shared D. Hadjiminas· 1 shared D. Patten· 1 shared

Activity by Year

2017-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. M. Boddy

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Automated analysis of PD1 and PDL1 in lymph nodes and the microenvironment of transmissible tumors in Tasmanian devils

G. G. Russell, C. Palmieri, J. Darby, G. P. Morris, N. M. Fountain-Jones, R. Pye, A. S. Flies

This study uses QuPath to analyze PD1 and PDL1 expression in Tasmanian devil lymph nodes, finding higher PD1 expression in germinal centers and increased PD1-positive cells in DFT2 metastases.

bioRxiv · Oct 31, 2022Immunology

AI-powered pan-species computational pathology: bridging clinic and wildlife care

K. AbdulJabbar, S. P. Castillo, K. Hughes, H. Davidson, A. M. Boddy, L. M. Abegglen, E. P. Murchinson, T. A. Graham, S. Spiro, C. Palmieri, Y. Yuan

This study develops a pan-species computational pathology atlas using AI to analyze cancer morphology across species, finding that accuracy varies with morphological similarity and introduces a new metric for veterinary applications.

bioRxiv · Mar 5, 2022 · PreprintCancer Biology

Enhancers mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancer.

D. Patten, G. Corleone, B. Gyorffy, E. Erdos, A. Saiakhova, K. Goddard, A. Vingiani, S. Shousha, L. S. Pongor, D. Hadjiminas, G. Schiavon, P. Barry, C. Palmieri, C. Coombes, P. Scacheri, , L. Magnani

This study maps enhancers in luminal breast cancer to reveal phenotypic heterogeneity and its evolutionary dynamics during treatment.

bioRxiv · Sep 26, 2017Cancer Biology